NYSE:EVH - New York Stock Exchange, Inc. - US30050B1017 - Common Stock - Currency: USD
EVOLENT HEALTH INC - A
NYSE:EVH (1/29/2025, 2:33:39 PM)
10.41
-0.01 (-0.1%)
The current stock price of EVH is 10.41 USD. In the past month the price decreased by -8.11%. In the past year, price decreased by -65%.
/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it...
/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, announced the...
Darwin Financial's Joshua Robinson talks to Benzinga about the firm's latest commodities deal, and more M&A news from this past week.
EVH earnings call for the period ending September 30, 2024.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 36.86 | 37.40B | ||
DOCS | DOXIMITY INC-CLASS A | 51.66 | 10.80B | ||
WAY | WAYSTAR HOLDING CORP | N/A | 6.98B | ||
CERT | CERTARA INC | 35.33 | 2.22B | ||
SDGR | SCHRODINGER INC | N/A | 1.85B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 14.83 | 1.81B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.79B | ||
PHR | PHREESIA INC | N/A | 1.68B | ||
HSTM | HEALTHSTREAM INC | 49.91 | 986.45M | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 936.77M | ||
DH | DEFINITIVE HEALTHCARE CORP | 14.4 | 758.63M | ||
SLP | SIMULATIONS PLUS INC | 60.2 | 677.23M |
Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. The company is headquartered in Arlington, Virginia and currently employs 4,700 full-time employees. The company went IPO on 2015-06-05. The firm offers three primary solutions: specialty care management services, total cost of care management and administrative services. The company provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.
EVOLENT HEALTH INC - A
800 N Glebe Rd Ste 500
Arlington VIRGINIA 22203 US
CEO: Seth Blackley
Employees: 4700
Company Website: https://www.evolenthealth.com/
Investor Relations: https://ir.evolenthealth.com/
Phone: 15713896000
The current stock price of EVH is 10.41 USD.
The exchange symbol of EVOLENT HEALTH INC - A is EVH and it is listed on the New York Stock Exchange, Inc. exchange.
EVH stock is listed on the New York Stock Exchange, Inc. exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for EVH, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of EVH.
EVH does not pay a dividend.
EVH will report earnings on 2025-02-19, after the market close.
The PE ratio for EVH is 11.44. This is based on the reported non-GAAP earnings per share of 0.91 and the current share price of 10.41 USD.
The outstanding short interest for EVH is 9.06% of its float.
ChartMill assigns a fundamental rating of 4 / 10 to EVH. Both the profitability and financial health of EVH have multiple concerns.
Over the last trailing twelve months EVH reported a non-GAAP Earnings per Share(EPS) of 0.91. The EPS decreased by 21.33% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -4.17% | ||
ROE | -8.5% | ||
Debt/Equity | 0.49 |
ChartMill assigns a Buy % Consensus number of 84% to EVH. The Buy consensus is the average rating of analysts ratings from 19 analysts.
For the next year, analysts expect an EPS growth of -15.27% and a revenue growth 31.22% for EVH